Clinical Trial Update: A Clinical Study With MT-102 in Subjects With Cancer Cachexia [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating MT-102 in subjects with cancer cachexia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• MT-102

Snippet

Sponsor: Akamis Bio | Conditions: Cancer Cachexia | Phase 2 | Status: COMPLETED